95 related articles for article (PubMed ID: 8120368)
21. Development of an I-Ag7-expressing antigen-presenting cell line: intrinsic molecular defect in compact I-Ag7 dimer generation.
Nabavieh A; Chou H; Volokhov I; Lee JE; Purdy LE; Elliott JF; Singh B; Madrenas J
J Autoimmun; 1998 Feb; 11(1):63-71. PubMed ID: 9480724
[TBL] [Abstract][Full Text] [Related]
22. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
Dang LH; Lien LL; Benacerraf B; Rock KL
J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
[TBL] [Abstract][Full Text] [Related]
23. Efficient presentation of multivalent antigens targeted to various cell surface molecules of dendritic cells and surface Ig of antigen-specific B cells.
Serre K; Machy P; Grivel JC; Jolly G; Brun N; Barbet J; Leserman L
J Immunol; 1998 Dec; 161(11):6059-67. PubMed ID: 9834089
[TBL] [Abstract][Full Text] [Related]
24. Regulation of B cell receptor-mediated MHC class II antigen processing by FcgammaRIIB1.
Wagle NM; Faassen AE; Kim JH; Pierce SK
J Immunol; 1999 Mar; 162(5):2732-40. PubMed ID: 10072518
[TBL] [Abstract][Full Text] [Related]
25. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules.
Rock KL; Rothstein L; Gamble S; Fleischacker C
J Immunol; 1993 Jan; 150(2):438-46. PubMed ID: 8419476
[TBL] [Abstract][Full Text] [Related]
26. CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing.
Chu RS; Askew D; Noss EH; Tobian A; Krieg AM; Harding CV
J Immunol; 1999 Aug; 163(3):1188-94. PubMed ID: 10415013
[TBL] [Abstract][Full Text] [Related]
27. Analysis of MHC class II presentation of particulate antigens of B lymphocytes.
Vidard L; Kovacsovics-Bankowski M; Kraeft SK; Chen LB; Benacerraf B; Rock KL
J Immunol; 1996 Apr; 156(8):2809-18. PubMed ID: 8609400
[TBL] [Abstract][Full Text] [Related]
28. Processing and presentation of self and foreign antigens by the renal proximal tubule.
Hagerty DT; Allen PM
J Immunol; 1992 Apr; 148(8):2324-30. PubMed ID: 1560195
[TBL] [Abstract][Full Text] [Related]
29. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
30. Virus infection blocks the processing and presentation of exogenous antigen with the major histocompatibility complex class II molecules.
Domanico SZ; Pierce SK
Eur J Immunol; 1992 Aug; 22(8):2055-62. PubMed ID: 1379185
[TBL] [Abstract][Full Text] [Related]
31. Temperature-induced stress abrogates co-stimulatory function in antigen-presenting cells.
Kuperberg G; Ellis J; Marcinkiewicz J; Chain BM
Eur J Immunol; 1991 Nov; 21(11):2791-5. PubMed ID: 1936123
[TBL] [Abstract][Full Text] [Related]
32. Length and sequence requirements of the cytoplasmic domain of the A beta molecule for class II-mediated B cell signaling.
Harton JA; Bishop GA
J Immunol; 1993 Nov; 151(10):5282-9. PubMed ID: 8228224
[TBL] [Abstract][Full Text] [Related]
33. The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation.
Vascotto F; Lankar D; Faure-André G; Vargas P; Diaz J; Le Roux D; Yuseff MI; Sibarita JB; Boes M; Raposo G; Mougneau E; Glaichenhaus N; Bonnerot C; Manoury B; Lennon-Duménil AM
J Cell Biol; 2007 Mar; 176(7):1007-19. PubMed ID: 17389233
[TBL] [Abstract][Full Text] [Related]
34. Single amino acid mutations in the murine MHC class II A beta cytoplasmic domain abrogate antigen presentation.
Laufer TM; Smiley ST; Ranger A; Clements VK; Ostrand-Rosenberg S; Glimcher LH
J Immunol; 1997 Dec; 159(12):5914-20. PubMed ID: 9550388
[TBL] [Abstract][Full Text] [Related]
35. Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells.
Soos JM; Morrow J; Ashley TA; Szente BE; Bikoff EK; Zamvil SS
J Immunol; 1998 Dec; 161(11):5959-66. PubMed ID: 9834077
[TBL] [Abstract][Full Text] [Related]
36. Antigen presentation by B lymphoma cells. Requirements for processing of exogenous antigen internalized through transferrin receptors.
McCoy KL; Gainey D; Inman JK; Stutzman R
J Immunol; 1993 Nov; 151(9):4583-94. PubMed ID: 8409420
[TBL] [Abstract][Full Text] [Related]
37. Processing of exogenous heat-aggregated (denatured) and particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation.
Schirmbeck R; Böhm W; Melber K; Reimann J
J Immunol; 1995 Nov; 155(10):4676-84. PubMed ID: 7594467
[TBL] [Abstract][Full Text] [Related]
38. Antiviral immune responses of mice lacking MHC class II or its associated invariant chain.
Battegay M; Bachmann MF; Burhkart C; Viville S; Benoist C; Mathis D; Hengartner H; Zinkernagel RM
Cell Immunol; 1996 Jan; 167(1):115-21. PubMed ID: 8548834
[TBL] [Abstract][Full Text] [Related]
39. Modulation of antigen presentation and class II expression by a class II-associated invariant chain peptide.
Zechel MA; Chaturvedi P; Lee-Chan EC; Rider BJ; Singh B
J Immunol; 1996 Jun; 156(11):4232-9. PubMed ID: 8666792
[TBL] [Abstract][Full Text] [Related]
40. Up-regulation of the MHC class II molecules on B cells by peptide ligands.
Agrawal B; Fraga E; Kane K; Singh B
J Immunol; 1994 Feb; 152(3):965-75. PubMed ID: 8301149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
